These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28982031)

  • 1. Direct thrombin inhibition with dabigatran attenuates pressure overload-induced cardiac fibrosis and dysfunction in mice.
    Dong A; Mueller P; Yang F; Yang L; Morris A; Smyth SS
    Thromb Res; 2017 Nov; 159():58-64. PubMed ID: 28982031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
    Bogatkevich GS; Ludwicka-Bradley A; Nietert PJ; Akter T; van Ryn J; Silver RM
    Arthritis Rheum; 2011 May; 63(5):1416-25. PubMed ID: 21312187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baicalin Attenuates Cardiac Dysfunction and Myocardial Remodeling in a Chronic Pressure-Overload Mice Model.
    Zhang Y; Liao P; Zhu M; Li W; Hu D; Guan S; Chen L
    Cell Physiol Biochem; 2017; 41(3):849-864. PubMed ID: 28214892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CXCR6 deficiency attenuates pressure overload-induced monocytes migration and cardiac fibrosis through downregulating TNF-α-dependent MMP9 pathway.
    Wang JH; Su F; Wang S; Lu XC; Zhang SH; Chen D; Chen NN; Zhong JQ
    Int J Clin Exp Pathol; 2014; 7(10):6514-23. PubMed ID: 25400729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ablation of biglycan attenuates cardiac hypertrophy and fibrosis after left ventricular pressure overload.
    Beetz N; Rommel C; Schnick T; Neumann E; Lother A; Monroy-Ordonez EB; Zeeb M; Preissl S; Gilsbach R; Melchior-Becker A; Rylski B; Stoll M; Schaefer L; Beyersdorf F; Stiller B; Hein L
    J Mol Cell Cardiol; 2016 Dec; 101():145-155. PubMed ID: 27789290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacologic inhibition of the enzymatic effects of tissue transglutaminase reduces cardiac fibrosis and attenuates cardiomyocyte hypertrophy following pressure overload.
    Shinde AV; Su Y; Palanski BA; Fujikura K; Garcia MJ; Frangogiannis NG
    J Mol Cell Cardiol; 2018 Apr; 117():36-48. PubMed ID: 29481819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priming with synthetic oligonucleotides attenuates pressure overload-induced inflammation and cardiac hypertrophy in mice.
    Velten M; Duerr GD; Pessies T; Schild J; Lohner R; Mersmann J; Dewald O; Zacharowski K; Klaschik S; Hilbert T; Hoeft A; Baumgarten G; Meyer R; Boehm O; Knuefermann P
    Cardiovasc Res; 2012 Dec; 96(3):422-32. PubMed ID: 22977006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure.
    Szabó Z; Magga J; Alakoski T; Ulvila J; Piuhola J; Vainio L; Kivirikko KI; Vuolteenaho O; Ruskoaho H; Lipson KE; Signore P; Kerkelä R
    Hypertension; 2014 Jun; 63(6):1235-40. PubMed ID: 24688123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-PBA prevents pressure overload-induced myocardial hypertrophy and interstitial fibrosis by attenuating endoplasmic reticulum stress.
    Luo T; Chen B; Wang X
    Chem Biol Interact; 2015 Dec; 242():99-106. PubMed ID: 26428355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The vitamin D receptor activator paricalcitol prevents fibrosis and diastolic dysfunction in a murine model of pressure overload.
    Meems LM; Cannon MV; Mahmud H; Voors AA; van Gilst WH; Silljé HH; Ruifrok WP; de Boer RA
    J Steroid Biochem Mol Biol; 2012 Nov; 132(3-5):282-9. PubMed ID: 22800987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous relaxin does not affect chronic pressure overload-induced cardiac hypertrophy and fibrosis.
    Xu Q; Lekgabe ED; Gao XM; Ming Z; Tregear GW; Dart AM; Bathgate RA; Samuel CS; Du XJ
    Endocrinology; 2008 Feb; 149(2):476-82. PubMed ID: 17991721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of dipeptidyl peptidase-4 on cardiac fibrosis in pressure overload-induced heart failure.
    Hirose M; Takano H; Hasegawa H; Tadokoro H; Hashimoto N; Takemura G; Kobayashi Y
    J Pharmacol Sci; 2017 Dec; 135(4):164-173. PubMed ID: 29249634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tenascin-C promotes chronic pressure overload-induced cardiac dysfunction, hypertrophy and myocardial fibrosis.
    Podesser BK; Kreibich M; Dzilic E; Santer D; Förster L; Trojanek S; Abraham D; Krššák M; Klein KU; Tretter EV; Kaun C; Wojta J; Kapeller B; Gonçalves IF; Trescher K; Kiss A
    J Hypertens; 2018 Apr; 36(4):847-856. PubMed ID: 29283973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olmesartan attenuates cardiac remodeling through DLL4/Notch1 pathway activation in pressure overload mice.
    You J; Wu J; Jiang G; Guo J; Wang S; Li L; Ge J; Zou Y
    J Cardiovasc Pharmacol; 2013 Feb; 61(2):142-51. PubMed ID: 23188126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Qindan Capsule Attenuates Myocardial Hypertrophy and Fibrosis in Pressure Overload-Induced Mice Involving mTOR and TGF-
    Bai W; Ren M; Cheng W; Lu X; Liu D; Wang B
    Evid Based Complement Alternat Med; 2021; 2021():5577875. PubMed ID: 34007292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects.
    Altieri P; Bertolotto M; Fabbi P; Sportelli E; Balbi M; Santini F; Brunelli C; Canepa M; Montecucco F; Ameri P
    Int J Cardiol; 2018 Nov; 271():219-227. PubMed ID: 29801760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role of rivaroxaban in attenuating pressure-overload-induced atrial fibrosis and fibrillation.
    Kondo H; Abe I; Fukui A; Saito S; Miyoshi M; Aoki K; Shinohara T; Teshima Y; Yufu K; Takahashi N
    J Cardiol; 2018 Mar; 71(3):310-319. PubMed ID: 28993090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRPA1 inhibition ameliorates pressure overload-induced cardiac hypertrophy and fibrosis in mice.
    Wang Z; Xu Y; Wang M; Ye J; Liu J; Jiang H; Ye D; Wan J
    EBioMedicine; 2018 Oct; 36():54-62. PubMed ID: 30297144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac hypertrophy is enhanced in PPAR alpha-/- mice in response to chronic pressure overload.
    Smeets PJ; Teunissen BE; Willemsen PH; van Nieuwenhoven FA; Brouns AE; Janssen BJ; Cleutjens JP; Staels B; van der Vusse GJ; van Bilsen M
    Cardiovasc Res; 2008 Apr; 78(1):79-89. PubMed ID: 18187461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
    Li CY; Chen YH; Wang Q; Hou JW; Wang H; Wang YP; Li YG
    J Hypertens; 2016 Sep; 34(9):1766-77. PubMed ID: 27379535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.